Literature DB >> 9130638

Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide.

J Goldstein1, H Mostowsky, J Tung, H Hon, M Brunswick, S Kozlowski.   

Abstract

In this report, we demonstrate stimulation of T cell receptor (TCR) transgenic CD8 T cells by isolated major histocompatibility complex (MHC) class I H-2Ld complexes and antigenic peptide. This is the first demonstration of CD8 T cells activated by MHC and antigenic peptide in the absence of antigen priming. Furthermore, isolated MHC and a potent peptide antigen can stimulate phenotypically naive CD44- T cells to become CTL effectors and to produce interleukin-2 in nanogram per milliliter amounts. These results demonstrate that particular TCR antigen pairs may overcome the need for specialized antigen-presenting cells and have implications for mechanisms of autoimmunity and tolerance induction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130638     DOI: 10.1002/eji.1830270411

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

Authors:  Qing Ge; Jennifer D Stone; M Todd Thompson; Jennifer R Cochran; Mia Rushe; Herman N Eisen; Jianzhu Chen; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

Review 2.  Soluble MHC class I complexes for targeted immunotherapy.

Authors:  Anna Schappert; Jonathan P Schneck; Lauren Suarez; Mathias Oelke; Christian Schütz
Journal:  Life Sci       Date:  2018-08-10       Impact factor: 5.037

3.  Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.

Authors:  S Casares; C S Zong; D L Radu; A Miller; C A Bona; T D Brumeanu
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

4.  MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth.

Authors:  Christian Schütz; Alessia Zoso; Shiwen Peng; Jonathon D Bennett; Jonathan P Schneck; Mathias Oelke
Journal:  Immun Inflamm Dis       Date:  2014-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.